| Date | Company | Compound | Disease | Type of agreement | Therapeutic area | Type of Information |
|---|---|---|---|---|---|---|
| 2015-06-22 | Valneva (France- Austria) GSK (UK) | Ixiaro®/Jespect® | Japanese encephalitis | distribution |
Infectious diseases | Termination of the agreement |
| 2015-06-19 | Incyte (USA - DE) | restructuring |
Cancer - Oncology - Rare diseases | Restructuring | ||
| 2015-06-18 | Emulate (USA - NC) Janssen Biotech, a J&J company (USA - NJ) | Organs-on-Chips platform (Thrombosis-on-Chip, Lung-on-Chip, Liver-on-Chip) | R&D collaboration |
Technology - Services | R&D agreement | |
| 2015-06-18 | Avexis (USA - IL) | nomination |
Rare diseases - Genetic diseases - Neurological diseases | Nomination | ||
| 2015-06-18 | Teva Pharmaceutical (Israel) Microchips Biotech (USA - MA) | implantable drug delivery device | collaboration |
undisclosed | Collaboration agreement | |
| 2015-06-18 | ITeos Therapeutics (Belgium) | nomination |
Cancer - Oncology | Nomination | ||
| 2015-06-18 | Axxam (Italy) MD Anderson Cancer Center (USA - TX) | collaboration R&D |
Cancer - Oncology | Collaboration agreement | ||
| 2015-06-17 | Pierre Fabre (France) ABCheck ( Czech Republic) | antibodies against an undisclosed number of targets provided by Pierre Fabre | undisclosed | R&D |
undisclosed | R&D agreement |
| 2015-06-17 | Asklepios BioPharmaceutical (USA - NC) Avexis (USA - IL) | Duplex vectors | licensing |
Technology - Services | Licensing agreement | |
| 2015-06-17 | Eli Lilly (USA - IN) Sarah Cannon Research Institute (SCRI) (USA - CO) | LY3023414 | development |
Cancer - Oncology | Development agreement | |
| 2015-06-17 | Eli Lilly (USA - IN) Dana-Farber Cancer Institute (USA - MA) | undisclosed early-stage Lilly oncology compounds | R&D |
Cancer - Oncology | R&D agreement | |
| 2015-06-17 | CSL (Australia) BioCryst Pharmaceuticals (USA - NC) | Rapivab® (peramivir injection) | influenza | licensing |
Infectious diseases | Licensing agreement |
| 2015-06-17 | BioInvent (Sweden) undisclosed leading U.S. biotechnology company (USA) | antibody library n-CoDeR® | undisclosed | licensing |
undisclosed | Licensing agreement |
| 2015-06-17 | Medday (France) DSM Nutritional Products (The Netherlands) | D-biotin | multiple sclerosis | production manufacturing supply |
CNS diseases - Neurological diseases - Neurodegenerative diseases | Production agreement |
| 2015-06-17 | Medday (France) DSM Nutritional Products (The Netherlands) | D-biotin | multiple sclerosis | production manufacturing supply |
CNS diseases - Neurological diseases - Neurodegenerative diseases | Production agreement |
| 2015-06-17 | Anika Therapeutics (USA – MA) Institute for Applied Life Sciences at the University of Massachusetts (UMass) Amherst (US - MA) | rheumatoid arthritis | R&D collaboration |
Autoimmune diseases – Inflammatory diseases - Rheumatic diseases | R&D agreement | |
| 2015-06-16 | Bayer Healthcare (Germany) Johns Hopkins University (USA - MD) | new ophthalmic therapies targeting retinal diseases | retinal diseases including age-related macular degeneration (AMD), diabetic macular edema (DME), geographic atrophy, Stargardt\'s disease, and retinal vein occlusion (RVO) | R&D |
Ophtalmological diseases | R&D agreement |
| 2015-06-16 | Aegerion Pharmaceuticals (USA - MA) | Rare diseases - Genetic diseases - Metabolic diseases | Nomination | |||
| 2015-06-16 | Vect-Horus (France) Servier (France) | peptide vectors | CNS diseases | collaboration |
CNS diseases | Collaboration agreement |
| 2015-06-16 | Debiopharm (Switzerland) Spinomix (Switzerland) | FibroTrap sample processing technology | product acquisition |
Technology - Services | Product acquisition |
